Study in Patients With SCLC of Veliparib in Combination With Topotecan
Clinical trial NCT03227016 · UNKNOWN
Trial details
- NCT number
- NCT03227016
- Sponsor
- Central European Society for Anticancer Drug Research
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2021-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.